References
- Clemow DB, Johnson KW, Hochstetler HM, et al. Lasmiditan mechanism of action – review of a selective 5-HT1F agonist. J Headache Pain. 2020;21(1):71.
- Spindler BL, Ryan M. Medications approved for preventing migraine headaches. Am J Med. 2020;133(6):664–667.
- DRUGBANK: Ergotamine; [updated 2020 Nov 23; cited 2020 Nov 24] Available from: https://go.drugbank.com/drugs/DB00696
- DRUGBANK: triptan; [cited 2020 Nov 24] Available from: https://go.drugbank.com/unearth/q?utf8=%E2%9C%93&searcher=drugs&query=triptans
- DRUGBANK: lasmiditan; [updated 2020 Nov 2; cited 2020 Nov 24]. Available from: https://go.drugbank.com/drugs/DB11732
- Maso BN, Russo AF. Vascular contributions to migraine: time to revisit? Front Cell Neurosci. 2018;3(12):233.
- De Vrie T, Villalón CM, MaassenVanDenBrink A. Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. Pharmacol Ther. 2020;211:107528.
- Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nat Rev Neurol. 2019;15(8):483–490.
- Borgdorff P. Arguments against the role of cortical spreading depression in migraine. Neurol Res. 2018;40(3):173–181.
- Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol. 2010;1:16.
- Knapp L, Szita B, Kocsis K, et al. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues. Drug Des Devel Ther. 2016;11:27–34.
- Tanaka M, Toldi J, Vécsei L. Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines. Int J Mol Sci. 2020;21:2431.
- Török N, Tanaka M, Vécsei L. Searching for peripheral biomarkers in neurodegenerative diseases: the tryptophan-kynurenine metabolic pathway. Int J Mol Sci. 2020;21:9338.
- Jovanovic F, Candido KD, Knezevic NN. The Role of the kynurenine signaling pathway in different chronic pain conditions and potential use of therapeutic agents. Int J Mol Sci. 2020;21:6045.
- Cortes-Altamirano JL, Olmos-Hernandez A, Jaime HB, et al. Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system. Curr Neuropharmacol. 2018;16(2):210–221.